Visceral Pleural Invasion as a Prognostic Factor for Recurrence in Resected IB Non-small Cell Lung Cancer
![]() |
Kim, Seok
(Department of Thoracic and Cardiovascular Surgery, Daegu Catholic Medical Center)
Park, Ki-Sung (Department of Thoracic and Cardiovascular Surgery, Daegu Catholic Medical Center) Kum, Yoon-Seup (Department of Pathology, Daegu Catholic Medical Center) Lee, Sub (Department of Thoracic and Cardiovascular Surgery, Daegu Catholic Medical Center) Bae, Chi-Hoon (Department of Thoracic and Cardiovascular Surgery, Daegu Catholic Medical Center) Hyun, Dae-Sung (Department of Internal Medicine, Daegu Catholic Medical Center) |
1 | International Adjuvant Lung Cancer Trial Collaborative Group. Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer. N Engl J Med 2004;350:351-60 DOI ScienceOn |
2 | Strauss GMH, Maddaus JE, Johnstone MA, et al. Adjuvant chemotherapy in stage IB non-small cell lung cancer (NSCLC): update of cancer and leukemia group B (CALGB) protocol 9633. J Clin Oncol 2006;24(suppl):7007 |
3 | Scagliotti GV, Fossati R, Torri V, et al. Randomized study of adjuvant chemotherapy for completely resected stage I, II, or IIIA non-small-cell Lung cancer. J Natl Cancer Inst 2003; 95:1453-61 DOI |
4 | Kurokawa T, Matsuno Y, Noguchi M, Mizuno S, Shimosato Y. Surgically curable "early" adenocarcinoma in the periphery of the lung. Am J Surg Pathol 1994;18:431-8 DOI |
5 | Padilla J, Calvo V, Penalver JC, et al. Survival and risk model for stage IB non-small cell lung cancer. Lung Cancer 2002;36:43-8 DOI ScienceOn |
6 | Thomas PA, Piantadosi S, and the Lung Cancer Study Group. Postoperative T1N0 non-small cell lung cancer. Squamous versus non-squamous recurrence. J Thorac Cardiovasc Surg 1987;94:349-54 |
7 | Suzuki K, Nagai K, Yoshida J, et al. Conventional clinicopathologic prognostic factors in surgically resected nonsmall cell lung carcinoma. Cancer 1999;86:1976-84 DOI ScienceOn |
8 | Harpole DH Jr, Herndon JE 2nd, Young WG Jr, et al. Stage I nonsmall cell lung cancer: a multivariate analysis of treatment methods and patterns of recurrence. Cancer 1995;76: 787-96 DOI ScienceOn |
9 | Sawyer TE, Bonner JA, Gould PM, et al. Patients with stage I non-small cell lung carcinoma at postoperative risk for local recurrence, distant metastasis, and death: implications related to the design of clinical trials. Int J Radiat Oncol Biol Phys 1999;45:315-21 |
10 | Mountain CF. Revisions in the international system for staging lung cancer. Chest 1997;111:1710-7 DOI PUBMED ScienceOn |
11 | Manac’h D, Riquet M, Medioni J, et al. Visceral pleura invasion by non-small cell lung cancer: an underrated bad prognostic factor. Ann Thorac Surg 2001;71:1088-93 DOI ScienceOn |
12 | Ravdin PM, Davis G. Prognosis of patients with resected non-small cell lung cancer: impact of clinical and pathologic variables. Lung Cancer 2006;52:207-12 DOI ScienceOn |
13 | Winton T, Livingston R, Johnson D, et al. Vinorelbine plus cisplatin vs. observation in resected non-small-cell lung cancer. N Engl J Med 2005;352:2589-97 DOI ScienceOn |
14 | Shimizu K, Yoshida J, Nagai K, et al. Visceral pleural invasion is as invasive and aggressive indicator of non-small cell lung cancer. J Thorac Cardiovasc Surg 2005;130:160-5 DOI ScienceOn |
15 | Read RC, Yoder G, Schafer RC. Survival after conservative resection for T1N0M0 non-small cell lung cancer. Ann Thorac Surg 1990;49:349-54 |
16 | Goya T, Asamura H, Yoshimura H, et al. Prognosis of 6644 resected non-small cell lung cancers in Japan. A Japanese lung cancer registry study. Lung Cancer 2005;50:227-34 DOI ScienceOn |
17 | Martini N, Bains MS, Burt ME, et al. Incidence of local recurrence and second primary tumors in resected stage I lung cancer. J Thorac Cardiovasc Surg 1995;109:120-9 DOI ScienceOn |
![]() |